Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001372709 | SCV001569391 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2022-12-14 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002493898 | SCV002778004 | uncertain significance | Alagille syndrome due to a JAG1 point mutation; Tetralogy of Fallot; Deafness, congenital heart defects, and posterior embryotoxon; Charcot-Marie-Tooth disease, axonal, Type 2HH | 2021-10-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004550092 | SCV004711027 | uncertain significance | JAG1-related disorder | 2023-11-22 | criteria provided, single submitter | clinical testing | The JAG1 c.3398C>T variant is predicted to result in the amino acid substitution p.Thr1133Met. This variant was reported in a study of patients with congenital hypothyroidism (Supplementary Table 4, Yamaguchi et al. 2020. PubMed ID: 32459320). This variant is reported in 0.035% of alleles in individuals of East Asian descent in gnomAD, which is more common than expected for a pathogenic variant for an autosomal dominant disorder. Although we suspect this variant may be benign, at this time its clinical significance is uncertain due to the absence of conclusive functional and genetic evidence. |